nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—CYP3A4—Temozolomide—malignant glioma	0.623	1	CbGbCtD
Indacaterol—Musculoskeletal pain—Temozolomide—malignant glioma	0.0111	0.0419	CcSEcCtD
Indacaterol—Diabetes mellitus—Carmustine—malignant glioma	0.0095	0.0358	CcSEcCtD
Indacaterol—Hypokalaemia—Carmustine—malignant glioma	0.00752	0.0283	CcSEcCtD
Indacaterol—Hypokalaemia—Temozolomide—malignant glioma	0.00727	0.0274	CcSEcCtD
Indacaterol—Hyperglycaemia—Carmustine—malignant glioma	0.00644	0.0243	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00642	0.0242	CcSEcCtD
Indacaterol—Pneumonia—Carmustine—malignant glioma	0.00641	0.0241	CcSEcCtD
Indacaterol—Hyperglycaemia—Temozolomide—malignant glioma	0.00623	0.0234	CcSEcCtD
Indacaterol—Pneumonia—Temozolomide—malignant glioma	0.00619	0.0233	CcSEcCtD
Indacaterol—Infestation NOS—Temozolomide—malignant glioma	0.00616	0.0232	CcSEcCtD
Indacaterol—Infestation—Temozolomide—malignant glioma	0.00616	0.0232	CcSEcCtD
Indacaterol—Sinusitis—Temozolomide—malignant glioma	0.00578	0.0217	CcSEcCtD
Indacaterol—Oedema peripheral—Carmustine—malignant glioma	0.00563	0.0212	CcSEcCtD
Indacaterol—Connective tissue disorder—Carmustine—malignant glioma	0.00562	0.0212	CcSEcCtD
Indacaterol—Oedema peripheral—Temozolomide—malignant glioma	0.00544	0.0205	CcSEcCtD
Indacaterol—Connective tissue disorder—Temozolomide—malignant glioma	0.00543	0.0204	CcSEcCtD
Indacaterol—Cardiac disorder—Temozolomide—malignant glioma	0.00513	0.0193	CcSEcCtD
Indacaterol—Immune system disorder—Temozolomide—malignant glioma	0.00499	0.0188	CcSEcCtD
Indacaterol—Mediastinal disorder—Temozolomide—malignant glioma	0.00498	0.0187	CcSEcCtD
Indacaterol—Malnutrition—Carmustine—malignant glioma	0.00498	0.0187	CcSEcCtD
Indacaterol—Malnutrition—Temozolomide—malignant glioma	0.00481	0.0181	CcSEcCtD
Indacaterol—Tremor—Carmustine—malignant glioma	0.00466	0.0176	CcSEcCtD
Indacaterol—Anaemia—Carmustine—malignant glioma	0.0046	0.0173	CcSEcCtD
Indacaterol—Tremor—Temozolomide—malignant glioma	0.00451	0.017	CcSEcCtD
Indacaterol—Anaemia—Temozolomide—malignant glioma	0.00445	0.0167	CcSEcCtD
Indacaterol—Vertigo—Temozolomide—malignant glioma	0.00432	0.0163	CcSEcCtD
Indacaterol—Palpitations—Temozolomide—malignant glioma	0.00425	0.016	CcSEcCtD
Indacaterol—Chest pain—Carmustine—malignant glioma	0.00424	0.016	CcSEcCtD
Indacaterol—Myalgia—Carmustine—malignant glioma	0.00424	0.016	CcSEcCtD
Indacaterol—Cough—Temozolomide—malignant glioma	0.0042	0.0158	CcSEcCtD
Indacaterol—Myalgia—Temozolomide—malignant glioma	0.0041	0.0154	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00407	0.0153	CcSEcCtD
Indacaterol—Infection—Carmustine—malignant glioma	0.00404	0.0152	CcSEcCtD
Indacaterol—Dry mouth—Temozolomide—malignant glioma	0.00401	0.0151	CcSEcCtD
Indacaterol—Tachycardia—Carmustine—malignant glioma	0.00397	0.0149	CcSEcCtD
Indacaterol—Infection—Temozolomide—malignant glioma	0.0039	0.0147	CcSEcCtD
Indacaterol—Nervous system disorder—Temozolomide—malignant glioma	0.00385	0.0145	CcSEcCtD
Indacaterol—Skin disorder—Temozolomide—malignant glioma	0.00381	0.0144	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0037	0.0139	CcSEcCtD
Indacaterol—Paraesthesia—Carmustine—malignant glioma	0.00365	0.0137	CcSEcCtD
Indacaterol—Dyspnoea—Carmustine—malignant glioma	0.00362	0.0136	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00358	0.0135	CcSEcCtD
Indacaterol—Paraesthesia—Temozolomide—malignant glioma	0.00353	0.0133	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Carmustine—malignant glioma	0.00351	0.0132	CcSEcCtD
Indacaterol—Dyspnoea—Temozolomide—malignant glioma	0.0035	0.0132	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00339	0.0128	CcSEcCtD
Indacaterol—Hypersensitivity—Carmustine—malignant glioma	0.00299	0.0113	CcSEcCtD
Indacaterol—Hypersensitivity—Temozolomide—malignant glioma	0.00289	0.0109	CcSEcCtD
Indacaterol—Pruritus—Temozolomide—malignant glioma	0.00278	0.0105	CcSEcCtD
Indacaterol—Dizziness—Carmustine—malignant glioma	0.00269	0.0101	CcSEcCtD
Indacaterol—Dizziness—Temozolomide—malignant glioma	0.0026	0.00977	CcSEcCtD
Indacaterol—Rash—Carmustine—malignant glioma	0.00256	0.00964	CcSEcCtD
Indacaterol—Dermatitis—Carmustine—malignant glioma	0.00256	0.00963	CcSEcCtD
Indacaterol—Headache—Carmustine—malignant glioma	0.00255	0.00958	CcSEcCtD
Indacaterol—Rash—Temozolomide—malignant glioma	0.00248	0.00932	CcSEcCtD
Indacaterol—Dermatitis—Temozolomide—malignant glioma	0.00247	0.00931	CcSEcCtD
Indacaterol—Headache—Temozolomide—malignant glioma	0.00246	0.00926	CcSEcCtD
Indacaterol—Nausea—Carmustine—malignant glioma	0.00241	0.00908	CcSEcCtD
Indacaterol—Nausea—Temozolomide—malignant glioma	0.00233	0.00878	CcSEcCtD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00011	0.000981	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SPHK1—malignant glioma	0.00011	0.00098	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000108	0.000967	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ASMT—malignant glioma	0.000108	0.000966	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000108	0.000966	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000108	0.000964	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR4—malignant glioma	0.000107	0.00096	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HEY1—malignant glioma	0.000107	0.00096	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SPHK1—malignant glioma	0.000107	0.000959	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000107	0.000953	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR4—malignant glioma	0.000105	0.000939	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HEY1—malignant glioma	0.000105	0.000939	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HIST1H3B—malignant glioma	0.000104	0.000933	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000104	0.000932	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—BCHE—malignant glioma	0.000103	0.000917	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HIST1H3B—malignant glioma	0.000102	0.000912	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—BCAN—malignant glioma	0.000102	0.000908	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SLC5A5—malignant glioma	0.000101	0.000905	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CXCL8—malignant glioma	9.97e-05	0.000892	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MMP3—malignant glioma	9.96e-05	0.00089	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.92e-05	0.000887	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CXCL8—malignant glioma	9.76e-05	0.000873	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MMP3—malignant glioma	9.74e-05	0.000871	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	9.68e-05	0.000865	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JAG2—malignant glioma	9.52e-05	0.000851	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.44e-05	0.000844	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JAG2—malignant glioma	9.31e-05	0.000833	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	9.09e-05	0.000813	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	8.21e-05	0.000734	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—IDH2—malignant glioma	8.19e-05	0.000732	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTP1—malignant glioma	8.16e-05	0.000729	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—H3F3A—malignant glioma	8.06e-05	0.00072	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—F2—malignant glioma	8e-05	0.000715	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCR3—malignant glioma	7.98e-05	0.000713	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CAT—malignant glioma	7.94e-05	0.00071	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—H3F3A—malignant glioma	7.88e-05	0.000705	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—COX8A—malignant glioma	7.83e-05	0.0007	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—F2—malignant glioma	7.83e-05	0.0007	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCR3—malignant glioma	7.81e-05	0.000698	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—YWHAE—malignant glioma	7.76e-05	0.000694	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NTRK2—malignant glioma	7.76e-05	0.000694	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FLT1—malignant glioma	7.73e-05	0.000691	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2B6—malignant glioma	7.7e-05	0.000688	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DUSP6—malignant glioma	7.69e-05	0.000688	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CG—malignant glioma	7.66e-05	0.000685	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JAG1—malignant glioma	7.6e-05	0.000679	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NTRK2—malignant glioma	7.59e-05	0.000679	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—YWHAE—malignant glioma	7.59e-05	0.000679	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH3—malignant glioma	7.56e-05	0.000676	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FLT1—malignant glioma	7.56e-05	0.000676	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	7.55e-05	0.000676	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DUSP6—malignant glioma	7.53e-05	0.000673	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—NCOR1—malignant glioma	7.5e-05	0.00067	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	7.49e-05	0.00067	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FBXW7—malignant glioma	7.44e-05	0.000665	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JAG1—malignant glioma	7.43e-05	0.000664	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	7.4e-05	0.000662	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	7.39e-05	0.000661	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BDKRB2—malignant glioma	7.3e-05	0.000653	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FBXW7—malignant glioma	7.28e-05	0.000651	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—F2—malignant glioma	7.26e-05	0.00065	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	7.14e-05	0.000638	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—F2—malignant glioma	7.11e-05	0.000635	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—IDH1—malignant glioma	7.04e-05	0.00063	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	7.04e-05	0.000629	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT2—malignant glioma	7e-05	0.000626	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.98e-05	0.000624	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CG—malignant glioma	6.95e-05	0.000622	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	6.85e-05	0.000613	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PTPN11—malignant glioma	6.83e-05	0.000611	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SPHK1—malignant glioma	6.81e-05	0.000609	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	6.8e-05	0.000608	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH2—malignant glioma	6.78e-05	0.000607	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CD—malignant glioma	6.73e-05	0.000602	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	6.68e-05	0.000597	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2C18—malignant glioma	6.67e-05	0.000597	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ASMT—malignant glioma	6.66e-05	0.000595	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KNG1—malignant glioma	6.64e-05	0.000594	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	6.64e-05	0.000593	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	6.58e-05	0.000589	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KNG1—malignant glioma	6.49e-05	0.000581	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	6.41e-05	0.000573	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT2—malignant glioma	6.36e-05	0.000569	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NTRK1—malignant glioma	6.33e-05	0.000566	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—BCAN—malignant glioma	6.26e-05	0.00056	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT2—malignant glioma	6.22e-05	0.000556	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	6.2e-05	0.000555	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NTRK1—malignant glioma	6.19e-05	0.000553	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CD—malignant glioma	6.11e-05	0.000546	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CAV1—malignant glioma	6.11e-05	0.000546	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	5.98e-05	0.000535	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP3—malignant glioma	5.88e-05	0.000526	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CB—malignant glioma	5.87e-05	0.000525	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	5.83e-05	0.000521	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP3—malignant glioma	5.75e-05	0.000515	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	5.74e-05	0.000513	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	5.7e-05	0.00051	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTK2—malignant glioma	5.66e-05	0.000506	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	5.64e-05	0.000504	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CG—malignant glioma	5.57e-05	0.000498	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HES1—malignant glioma	5.56e-05	0.000497	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTK2—malignant glioma	5.54e-05	0.000495	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NCOR1—malignant glioma	5.53e-05	0.000495	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	5.51e-05	0.000493	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—RAF1—malignant glioma	5.46e-05	0.000488	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HES1—malignant glioma	5.44e-05	0.000487	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NCOR1—malignant glioma	5.41e-05	0.000484	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTT1—malignant glioma	5.4e-05	0.000483	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—IL2—malignant glioma	5.39e-05	0.000482	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPARG—malignant glioma	5.37e-05	0.00048	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—RAF1—malignant glioma	5.34e-05	0.000477	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	5.33e-05	0.000476	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	5.3e-05	0.000474	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—IL2—malignant glioma	5.27e-05	0.000471	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	5.24e-05	0.000468	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	5.21e-05	0.000466	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	5.18e-05	0.000463	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SPP1—malignant glioma	5.14e-05	0.00046	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	5.12e-05	0.000458	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS1—malignant glioma	5.06e-05	0.000452	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—IDH2—malignant glioma	5.04e-05	0.000451	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SPP1—malignant glioma	5.03e-05	0.00045	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	5.01e-05	0.000448	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CD—malignant glioma	4.89e-05	0.000438	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL2—malignant glioma	4.89e-05	0.000437	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TERT—malignant glioma	4.87e-05	0.000436	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL2—malignant glioma	4.79e-05	0.000428	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TERT—malignant glioma	4.77e-05	0.000426	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDGFB—malignant glioma	4.76e-05	0.000425	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.74e-05	0.000424	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGFR1—malignant glioma	4.73e-05	0.000423	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—BCHE—malignant glioma	4.7e-05	0.000421	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HIF1A—malignant glioma	4.66e-05	0.000417	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDGFB—malignant glioma	4.65e-05	0.000416	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC5A5—malignant glioma	4.65e-05	0.000415	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGFR1—malignant glioma	4.63e-05	0.000414	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HIF1A—malignant glioma	4.56e-05	0.000408	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CAV1—malignant glioma	4.51e-05	0.000403	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KDR—malignant glioma	4.46e-05	0.000399	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CAV1—malignant glioma	4.41e-05	0.000394	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KDR—malignant glioma	4.36e-05	0.00039	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—IDH1—malignant glioma	4.34e-05	0.000388	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FN1—malignant glioma	4.29e-05	0.000384	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—F2—malignant glioma	4.29e-05	0.000384	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.28e-05	0.000383	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CB—malignant glioma	4.26e-05	0.000381	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BAD—malignant glioma	4.24e-05	0.000379	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—malignant glioma	4.23e-05	0.000378	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	4.2e-05	0.000376	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FN1—malignant glioma	4.2e-05	0.000375	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—F2—malignant glioma	4.2e-05	0.000375	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SPHK1—malignant glioma	4.2e-05	0.000375	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BAD—malignant glioma	4.15e-05	0.000371	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD80—malignant glioma	4.11e-05	0.000368	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.11e-05	0.000368	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	4.11e-05	0.000367	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APC—malignant glioma	4.11e-05	0.000367	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	4.11e-05	0.000367	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGF—malignant glioma	4.06e-05	0.000363	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTPN11—malignant glioma	4.03e-05	0.000361	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD80—malignant glioma	4.02e-05	0.00036	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	4.02e-05	0.000359	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APC—malignant glioma	4.02e-05	0.000359	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGF—malignant glioma	3.97e-05	0.000355	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTPN11—malignant glioma	3.95e-05	0.000353	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BRAF—malignant glioma	3.86e-05	0.000345	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BRAF—malignant glioma	3.78e-05	0.000338	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT2—malignant glioma	3.76e-05	0.000336	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTP1—malignant glioma	3.74e-05	0.000335	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EGFR—malignant glioma	3.74e-05	0.000335	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTEN—malignant glioma	3.69e-05	0.00033	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT2—malignant glioma	3.68e-05	0.000329	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EGFR—malignant glioma	3.66e-05	0.000327	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CAT—malignant glioma	3.64e-05	0.000326	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	3.61e-05	0.000323	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	3.58e-05	0.00032	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—KRAS—malignant glioma	3.53e-05	0.000316	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	3.53e-05	0.000316	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	3.5e-05	0.000313	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—KRAS—malignant glioma	3.46e-05	0.000309	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGF2—malignant glioma	3.46e-05	0.000309	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NCOR1—malignant glioma	3.44e-05	0.000307	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGF2—malignant glioma	3.38e-05	0.000302	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTT1—malignant glioma	3.33e-05	0.000297	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	3.25e-05	0.00029	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MDM2—malignant glioma	3.23e-05	0.000289	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RAF1—malignant glioma	3.22e-05	0.000288	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB2—malignant glioma	3.19e-05	0.000285	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	3.18e-05	0.000284	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MDM2—malignant glioma	3.16e-05	0.000283	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RAF1—malignant glioma	3.15e-05	0.000282	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	3.15e-05	0.000281	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB2—malignant glioma	3.12e-05	0.000279	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS1—malignant glioma	3.12e-05	0.000279	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	3.08e-05	0.000275	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CXCL8—malignant glioma	3.02e-05	0.00027	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CXCL8—malignant glioma	2.96e-05	0.000265	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	2.92e-05	0.000261	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—BCHE—malignant glioma	2.9e-05	0.000259	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP3—malignant glioma	2.89e-05	0.000259	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2—malignant glioma	2.89e-05	0.000258	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.86e-05	0.000256	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	2.86e-05	0.000256	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP3—malignant glioma	2.83e-05	0.000253	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2—malignant glioma	2.83e-05	0.000253	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CAV1—malignant glioma	2.8e-05	0.000251	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—malignant glioma	2.74e-05	0.000245	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTEN—malignant glioma	2.72e-05	0.000243	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—malignant glioma	2.68e-05	0.000239	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTEN—malignant glioma	2.66e-05	0.000238	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT1—malignant glioma	2.65e-05	0.000237	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CA—malignant glioma	2.6e-05	0.000232	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT1—malignant glioma	2.59e-05	0.000232	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CG—malignant glioma	2.55e-05	0.000228	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPARG—malignant glioma	2.46e-05	0.00022	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—malignant glioma	2.46e-05	0.00022	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT3—malignant glioma	2.43e-05	0.000217	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—malignant glioma	2.4e-05	0.000215	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT3—malignant glioma	2.38e-05	0.000213	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTP1—malignant glioma	2.31e-05	0.000206	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—malignant glioma	2.26e-05	0.000202	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CD—malignant glioma	2.24e-05	0.000201	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CAT—malignant glioma	2.24e-05	0.000201	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—malignant glioma	2.21e-05	0.000198	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGFR—malignant glioma	2.21e-05	0.000198	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGFR—malignant glioma	2.16e-05	0.000193	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AKT1—malignant glioma	2.12e-05	0.00019	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NCOR1—malignant glioma	2.12e-05	0.000189	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KRAS—malignant glioma	2.09e-05	0.000187	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KRAS—malignant glioma	2.04e-05	0.000183	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CB—malignant glioma	1.96e-05	0.000175	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—malignant glioma	1.94e-05	0.000173	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	1.92e-05	0.000172	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	1.88e-05	0.000168	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—malignant glioma	1.86e-05	0.000166	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—malignant glioma	1.82e-05	0.000162	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CAV1—malignant glioma	1.73e-05	0.000154	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTEN—malignant glioma	1.69e-05	0.000151	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.57e-05	0.000141	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT1—malignant glioma	1.57e-05	0.00014	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT1—malignant glioma	1.53e-05	0.000137	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPARG—malignant glioma	1.52e-05	0.000136	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.38e-05	0.000124	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.21e-05	0.000108	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—malignant glioma	1.19e-05	0.000107	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CA—malignant glioma	1.19e-05	0.000107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTEN—malignant glioma	1.04e-05	9.31e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKT1—malignant glioma	9.74e-06	8.71e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.35e-06	6.57e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKT1—malignant glioma	6e-06	5.37e-05	CbGpPWpGaD
